Submitted by Anonymous (not verified) on 12 September 2023 - 13:00
Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, HIV Infections, Date of authorisation: 10/06/2022, Revision: 14, Status: Authorised
Source: